Evidence for Stress-like Alterations in the HPA-Axis in Women Taking Oral Contraceptives

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Hertel, Johannes ^a,b   König, Johanna ^a   Homuth, Georg ^a   Van Der Auwera, Sandra ^a,b   Wittfeld, Katharina ^b   Pietzner, Maik ^a,c   Kacprowski, Tim ^a,c   Pfeiffer, Liliane ^e   Kretschmer, Anja ^e   Waldenberger, Melanie ^e   Kastenmüller, Gabi ^e   Artati, Anna ^e   Suhre, Karsten ^e,f   Adamski, Jerzy ^e,g,h   Langner, Sönke ^a   Völker, Uwe ^a,c   Völzke, Henry ^a,c   Nauck, Matthias ^a,c   Friedrich, Nele ^a,c,d   Grabe, Hans Joergen ^a,b  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^b GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^c DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^d GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^e INSTITUTE OF EPIDEMIOLOGY   (Germany)

^f WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^g GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^h TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FK 506 BINDING PROTEIN; GLUCOCORTICOID RECEPTOR; ORAL CONTRACEPTIVE AGENT; PHOSPHOLIPID; TACROLIMUS BINDING PROTEIN 5; TRIACYLGLYCEROL;

ADULT; BLOOD; BRAIN; CHEMICALLY INDUCED; DIAGNOSTIC IMAGING; DNA METHYLATION; DRUG EFFECT; FEMALE; GENETICS; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS; INTRON; MENTAL STRESS; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN SIZE; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; YOUNG ADULT;

ADULT; BRAIN; CONTRACEPTIVES, ORAL; DNA METHYLATION; FEMALE; HUMANS; HYPOTHALAMUS; INTRONS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; ORGAN SIZE; PHOSPHOLIPIDS; PITUITARY-ADRENAL SYSTEM; RECEPTORS, GLUCOCORTICOID; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL; TACROLIMUS BINDING PROTEINS; TRIGLYCERIDES; YOUNG ADULT;

EID: 85032496411     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-13927-7     Document Type: Article

References (58)

1. World Health Organization. 19th WHO Model List of Essential Medicines (2015).
2. United Nations, Department of Economic and Social Affairs, Population Division. Trends in Contraceptive Use Worldwide 2015. (ST/ESA/SER.A/349) (2015).
3. Oinonen, K. A. & Mazmanian, D. To what extent do oral contraceptives influence mood and affect? Journal of affective disorders 70, 229-240 (2002).
4. Young, E. A. et al. Influences of hormone-based contraception on depressive symptoms in premenopausal women with major depression. Psychoneuroendocrinology 32, 843-853 (2007).
5. Zethraeus, N. et al. A first-choice combined oral contraceptive influences general well-being in healthy women: a double-blind, randomized, placebo-controlled trial. Fertility and sterility 107, 1238-1245 (2017).
6. Skovlund, C. W., Morch, L. S., Kessing, L. V. & Lidegaard, O. Association of Hormonal Contraception With Depression. JAMA psychiatry (2016).
7. Meulenberg, P., Ross, H. A., Swinkels, L. & Benraad, T. J. The effect of oral contraceptives on plasma-free and salivary cortisol and cortisone. Clinica Chimica Acta 165, 379-385 (1987).
8. McQuaid, R. J. et al. Relations between plasma oxytocin and cortisol: The stress buffering role of social support. Neurobiology of stress 3, 52-60 (2016).
9. Briggs, M. H., Pitchford, A. G., Staniford, M., Barker, H. M. & Taylor, D. Metabolic effects of steroid contraceptives. Advances in Steroid Biochemistry and Pharmacology 2, 111-222 (1970).
10. Miller, G. E., Chen, E. & Zhou, E. S. If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-Adrenocortical axis in humans. Psychological bulletin 133, 25-45 (2007).
11. Holsboer, F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology 23, 477-501 (2000).
12. van Uum, S. H. M. et al. Elevated content of cortisol in hair of patients with severe chronic pain: a novel biomarker for stress. Stress (Amsterdam, Netherlands) 11, 483-488 (2008).
13. Gould, E. & Tanapat, P. Stress and hippocampal neurogenesis. Biological Psychiatry 46, 1472-1479 (1999).
14. Oomen, C. A. et al. Opposite effects of early maternal deprivation on neurogenesis in male versus female rats. PloS one 4, e3675 (2009).
15. Vega-Rivera, N. M., Fernández-Guasti, A., Ramírez-Rodríguez, G. & Estrada-Camarena, E. Forced swim and chronic variable stress reduced hippocampal cell survival in OVX female rats. Behavioural brain research 270, 248-255 (2014).
16. Barha, C. K., Brummelte, S., Lieblich, S. E. & Galea, L. A. M. Chronic restraint stress in adolescence differentially influences hypothalamic-pituitary-Adrenal axis function and adult hippocampal neurogenesis in male and female rats. Hippocampus 21, 1216-1227 (2011).
17. Brummelte, S. & Galea, L. A. M. Chronic high corticosterone reduces neurogenesis in the dentate gyrus of adult male and female rats. Neuroscience 168, 680-690 (2010).
18. Binder, E. B. The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology 34, S186-S195 (2009).
19. Klengel, T. et al. Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nature neuroscience 16, 33-41 (2013).
20. Fujii, T. et al. Effect of the common functional FKBP5 variant (rs1360780) on the hypothalamic-pituitary-Adrenal axis and peripheral blood gene expression. Psychoneuroendocrinology 42, 89-97 (2014).
21. Wochnik, G. M. et al. FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. The Journal of biological chemistry 280, 4609-4616 (2005).
22. Appel, K. et al. Moderation of adult depression by a polymorphism in the FKBP5 gene and childhood physical abuse in the general population. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology 36, 1982-1991 (2011).
23. Binder, E. B. et al. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nature genetics 36, 1319-1325 (2004).
24. Yeo, S. et al. The influence of FKBP5 genotype on expression of FKBP5 and other glucocorticoid-regulated genes, dependent on trauma exposure. Genes, brain, and behavior (2016).
25. Zimmermann, P. et al. Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: results from a 10-year prospective community study. The American journal of psychiatry 168, 1107-1116 (2011).
26. Höhne, N. et al. FKBP5 genotype-dependent DNA methylation and mRNA regulation after psychosocial stress in remitted depression and healthy controls. The international journal of neuropsychopharmacology 18 (2014).
27. Yehuda, R. et al. Holocaust Exposure Induced Intergenerational Effects on FKBP5 Methylation. Biological Psychiatry 80, 372-380 (2016).
28. Grabe, H. J. et al. Effect of the interaction between childhood abuse and rs1360780 of the FKBP5 gene on gray matter volume in a general population sample. Human brain mapping 37, 1602-1613 (2016).
29. Faria, R. et al. Alterations in phospholipidomic profile in the brain of mouse model of depression induced by chronic unpredictable stress. Neuroscience 273, 1-11 (2014).
30. Oliveira, T. G. et al. The impact of chronic stress on the rat brain lipidome. Molecular psychiatry 21, 80-88 (2016).
31. Gulbins, E. et al. Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugs. Nature medicine 19, 934-938 (2013).
32. Völzke, H. et al. Cohort profile: the study of health in Pomerania. International journal of epidemiology 40, 294-307 (2011).
33. D'Agostino, R. B. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Statist. Med. 17, 2265-2281 (1998).
34. Macfarlane, D. P., Forbes, S. & Walker, B. R. Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome. The Journal of endocrinology 197, 189-204 (2008).
35. Prodam, F. et al. High-end normal adrenocorticotropic hormone and cortisol levels are associated with specific cardiovascular risk factors in pediatric obesity: a cross-sectional study. BMC medicine 11, 44 (2013).
36. Polman, J. A. E. et al. Glucocorticoids modulate the mTOR pathway in the hippocampus: differential effects depending on stress history. Endocrinology 153, 4317-4327 (2012).
37. Papke, L. E. & Wooldridge, J. M. Econometric methods for fractional response variables with an application to 401(k) plan participation rates. J. Appl. Econ. 11, 619-632 (1996).
38. Pham, K., Nacher, J., Hof, P. R. & McEwen, B. S. Repeated restraint stress suppresses neurogenesis and induces biphasic PSA-NCAM expression in the adult rat dentate gyrus. European Journal of Neuroscience 17, 879-886 (2003).
39. Snyder, J. S., Soumier, A., Brewer, M., Pickel, J. & Cameron, H. A. Adult hippocampal neurogenesis buffers stress responses and depressive behaviour. Nature 476, 458-461 (2011).
40. Ising, M. et al. Polymorphisms in the FKBP5 gene region modulate recovery from psychosocial stress in healthy controls. The European journal of neuroscience 28, 389-398 (2008).
41. Lavebratt, C., Aberg, E., Sjoholm, L. K. & Forsell, Y. Variations in FKBP5 and BDNF genes are suggestively associated with depression in a Swedish population-based cohort. Journal of affective disorders 125, 249-255 (2010).
42. Herbert, J. Cortisol and depression: three questions for psychiatry. Psychological medicine 43, 449-469 (2013).
43. Kutner, S. J. & Brown, W. L. Types of oral contraceptives, depression, and premenstrual symptoms. The Journal of nervous and mental disease 155, 153-162 (1972).
44. Smith, E., Hay, P., Campbell, L. & Trollor, J. N. A review of the association between obesity and cognitive function across the lifespan: implications for novel approaches to prevention and treatment. Obesity reviews: an official journal of the International Association for the Study of Obesity 12, 740-755 (2011).
45. Janowitz, D. et al. Association between waist circumference and gray matter volume in 2344 individuals from two adult communitybased samples. NeuroImage 122, 149-157 (2015).
46. Mapstone, M. et al. Plasma phospholipids identify antecedent memory impairment in older adults. Nature medicine 20, 415-418 (2014).
47. Beck, A. T. & Steer, R. A. Beck Depression Inventory-Manual (The Psychological Coporation, San Antonio, 1987).
48. Wahl, I. et al. Standardization of depression measurement: a common metric was developed for 11 self-report depression measures. Journal of clinical epidemiology 67, 73-86 (2014).
49. Wittchen, H. U. DIA-X-Interviews: Manual für Screening Verfahren und Interview; Interviewheft Längsschnittuntersuchung (DIA-XLifetime); Ergänzungsheft (DIA-X-Lifetime); Interviewheft Querschnittsuntersuchung (DIA-X-12 Monate); Ergänzungsheft (DIA-X-12 Monate) (Swets & Zeitlinger, Frankfurt, 1997).
50. Wittchen, H. U. & Pfister, H. Diagnostisches Expertensystem für psychische Störungen (Swets & Zeitlinger, Frankfurt, 1997).
51. Bernstein, D. P. et al. Development and validation of a brief screening version of the Childhood Trauma Questionnaire. Child Abuse & Neglect 27, 169-190 (2003).
52. ATC-Index. Anatomisch-therapeutisch-chemische Klassifikation mit Tagesdosen. Amtliche Fassung des ATC-Index mit DD-Angaben für Deutschland (2007).
53. Ehrich, M. et al. Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proceedings of the National Academy of Sciences of the United States of America 102, 15785-15790 (2005).
54. Schurmann, C. et al. Analyzing illumina gene expression microarray data from different tissues: methodological aspects of data analysis in the metaxpress consortium. PloS one 7, e50938 (2012).
55. Knacke, H. et al. Metabolic fingerprints of circulating IGF-I and the IGF-I/IGFBP-3 ratio: a multi-fluid metabolomics study. The Journal of clinical endocrinology and metabolism, jc20162588 (2016).
56. Evans, A. M., DeHaven, C. D., Barrett, T., Mitchell, M. & Milgram, E. Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Analytical chemistry 81, 6656-6667 (2009).
57. Saadati, M. & Benner, A. Statistical challenges of high-dimensional methylation data. Statistics in medicine 33, 5347-5357 (2014).
58. Wahl, S. et al. On the potential of models for location and scale for genome-wide DNA methylation data. BMC bioinformatics 15, 232 (2014).